Hoareau, Raphaël
Bach-Gansmo, Tore
Cumming, Paul
Olberg, Dag Erlend https://orcid.org/0000-0001-7630-675X
Funding for this research was provided by:
Helse Sør-Øst RHF
Article History
Received: 7 December 2021
Accepted: 3 March 2022
First Online: 4 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: DEO is an employee of Norwegian Medical Cyclotron centre Ltd. The fluoride-18 SPE radiolabeling of <sup>18</sup>F-Py-TFP labeling agent is patented. The other authors declare no conflict of interest.